Add BrightSurf on Google Email

Landmark heart treatment study

A landmark study published in JAMA found that catheter ablation significantly improves quality of life and reduces symptoms of atrial fibrillation compared to drug therapy. The treatment, which destroys abnormal heart tissue, resulted in a 66% success rate for patients with no recurrent irregular heartbeats or symptoms.

SourceLoyola Medicine·JournalJournal of the American Medical Association·DateJan 26, 2010

Disparity in use of implantable devices to prevent sudden death in heart failure patients

A study published in the December 2009 issue of HeartRhythm found that only half of eligible heart failure patients received implantable cardioverter-defibrillators (ICDs) to prevent sudden cardiac death. The study also revealed wide variations in ICD use, with certain patient groups more likely to receive the devices.

SourceUniversity of Maryland Medical Center·JournalHeartRhythm Case Reports·DateDec 18, 2009

Most eligible patients miss out on cardiac resynchronization therapy for heart failure

A large-scale study found that less than half of eligible patients with heart failure receive cardiac resynchronization therapy (CRT) devices. The therapy is particularly beneficial for patients with disorganized heartbeats, but widespread variations in CRT use were observed among practices and patient characteristics.

SourceUniversity of South Florida (USF Health)·JournalAmerican Heart Journal·DateDec 11, 2009

ACC/AHA revised guidelines for the perioperative use of beta blockers to minimize cardiac risk

The American College of Cardiology and American Heart Association release updated guidelines recommending the use of beta blockers in high-risk cardiac patients undergoing noncardiac surgery to minimize cardiac risk. The guidelines emphasize careful patient selection, dose adjustment, and monitoring throughout the perioperative period.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateNov 2, 2009

New insights into cardiac aging

A study published in Aging Cell found that the conserved protein d4eBP protects heart function against aging, revealing a potential mechanism for cardiac aging. The research also sheds light on the TOR and FoxO signaling pathways, with implications for human heart health.

SourceSanford Burnham Prebys·JournalAging Cell·DateSep 14, 2009

Half of eligible patients not getting mitral valve surgery, U-M study shows

A recent study by the University of Michigan Cardiovascular Center found that only half of eligible patients with moderate to severe mitral regurgitation underwent surgery, despite meeting at least one indication for treatment. The study suggests that cardiologists may overestimate surgical risks and underestimate potential benefits.

SourceMichigan Medicine - University of Michigan·JournalJournal of the American College of Cardiology·DateSep 11, 2009

EuroHeart 2009

Research highlights striking differences in national prevention policies and cardiovascular mortality rates across EU countries, with Hungary and Greece showing highest rates. The study also found noticeable disparities in risk factor prevalence and CHD prevention policies among the 16 participating countries.

Results from the Kyoto heart study

The KYOTO HEART Study found that valsartan significantly reduced the incidence of cardiovascular events, including angina pectoris and stroke/TIA, in Japanese hypertensive patients. The study showed a lower rate of primary endpoints in the valsartan arm compared to non-ARB conventional therapies.

Carbon monoxide linked to heart problems in elderly

A nationwide study found that elevated carbon monoxide levels, even below national limits, are associated with an increased risk of hospitalization for cardiovascular disease among seniors. The study suggests an under-recognized health risk to seniors, highlighting the need for re-evaluation of health-based standards.

Cardiac arrest resuscitation: Passive oxygen flow better than assisted ventilation

A new study from Arizona suggests passive oxygen flow is more effective than assisted ventilation in treating patients experiencing cardiac arrest outside of a hospital setting. The modified protocol, called Cardiocerebral Resuscitation, resulted in higher survival rates compared to conventional bag-valve-mask ventilation.

SourceUniversity of Arizona Health Sciences·JournalAnnals of Emergency Medicine·DateAug 11, 2009